5 Firms Guide Drug-Delivery Firm's $374M SPAC Merger
Drug-delivery firm Starton Therapeutics Inc. and special purpose acquisition company Healthwell Acquisition Corp. I agreed on Thursday to a merger that would take Starton public at an estimated $374 million value,...To view the full article, register now.
Already a subscriber? Click here to view full article